XML 52 R43.htm IDEA: XBRL DOCUMENT v3.23.2
Stock-Based Compensation - Schedule of Activity under 2008 Plan and 2018 Plan (Details)
$ / shares in Units, shares in Thousands, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Number of Options (In Thousands)    
Beginning balance (in shares) | shares 14,215  
Options granted (in shares) | shares 5,029  
Options exercised (in shares) | shares (351)  
Options forfeited (in shares) | shares (2,494)  
Options expired (in shares) | shares (375)  
Ending balance (in shares) | shares 16,024 14,215
Vested and expected to vest (in shares) | shares 15,556  
Exercisable (in shares) | shares 9,303  
Weighted Average Exercise Price    
Beginning balance (in dollars per share) | $ / shares $ 14.74  
Options granted (in dollars per share) | $ / shares 4.32  
Options exercised (in dollars per share) | $ / shares 1.90  
Options forfeited (in dollars per share) | $ / shares 11.42  
Options expired (in dollars per shares) | $ / shares 14.80  
Ending balance (in dollars per share) | $ / shares 12.27 $ 14.74
Vested and expected to vest, weighted average exercise price (in dollars per share) | $ / shares 12.35  
Exercisable, weighted average exercise price (in dollars per share) | $ / shares $ 14.51  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]    
Weighted Average Remaining Contractual Life (In Years) 6 years 2 months 26 days 6 years 10 months 20 days
Vested and expected to vest, weighted average remaining contractual life 6 years 1 month 28 days  
Exercisable, weighted average remaining contractual life 4 years 1 month 20 days  
Aggregate intrinsic value | $ $ 40 $ 1,749
Vested and expected to vest, aggregate intrinsic value | $ 40  
Exercisable, aggregate intrinsic value | $ $ 40